Atlas Trials

A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated

Clinical trial NCT03953807 · COMPLETED

Trial details

NCT number
NCT03953807
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2019-09-05
Primary completion
2022-07-04
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.